摘要
本文分析50例(甲组)非手术治疗的中晚期肝癌行TAE后二期手术切除的临床疗效,并将生存率及肿瘤复发情况与42例(乙组)单纯重复行TAE治疗的中晚期肝癌相比较。结果:甲组一、二年累计生存率分别为71%、50%,乙组为73%和43%,二组间无显著差异。甲组OkudaⅠ期患者的生存率优于乙组,而OkudaⅡ期患者的生存率乙组优于甲组。认为中晚期肝癌行TAE后二期手术切除的必要性尚有待讨论,二期切除不能改善OkudaⅡ期患者的生存情况。
Objective. To study the alternative treatment of unresectable hepatocellular carcinoma.Matrials and methods. 50 patients with unresectable hepatocellular carcinoma(HCC) underwent secondary resection after TAE(Group A)and 42 patients with HCC were treated with repeated TAE(Groupp B).The therapeutic results obtained in two groups were retrospective analyzed and compared.Results. The 1-year,2-year cumulative survival rates of Group A were 71% and 50%,respectively. However, the rate were 73% and 43%, respectively, for the patients in Group B;these differences were not statistically significant. The cumulative survival in patients in Okuda' stage Ⅰ of Group A were significantly longer than that of Group B. In contrast,the survival rate of patients in Okuda's stage Ⅱ of Group A were worse than that of Group B.Conclusion. These results indicate that the secondary surgery after TAE for unresctable hepatocellular carcinoma should be well discussed.This treatment can not offer nore favorable results in patients in Okuda's stage Ⅱ compared with repeated TAE.
出处
《胃肠病学和肝病学杂志》
CAS
1996年第2期37-40,共4页
Chinese Journal of Gastroenterology and Hepatology